---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-002071"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:09:12.378555+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics acquires Boston Orthotics & Prosthetics for $22M cash plus stock; secures $80M debt financing

## Summary
- Acquired Boston O&P for $22M upfront cash plus ~83,000 restricted shares (~$2.5M) to employees.
- Boston O&P has ~$25M annual revenue, 26 patient care clinics, and partnerships with major children's hospitals.
- Acquisition expands OrthoPediatrics' Specialty Bracing division into $500M U.S. pediatric orthotic bracing market.
- Closed $80M credit facility with MidCap Financial (term loan $30M, revolver $50M), replacing prior $50M line.
- Combined entities have helped over 1 million children; targeting all 300 high-volume children's hospitals.

## SEC filing metadata
- accession: 0001104659-24-002071
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/0001104659-24-002071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/tm242260d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-002071
- JSON: https://secwatch.observer/filing/0001104659-24-002071.json
- Plain text: https://secwatch.observer/filing/0001104659-24-002071.txt

## Key facts
- Material Agreements
  ORTHOPEDIATRICS CORP entered into Stock Purchase Agreement with Boston Brace International, Inc., the shareholders of Boston Brace (collectively, the Sellers) valued at $22 million in cash (effective 2024-01-05).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Boston Brace International, Inc., the shareholders of Boston Brace (collectively, the Sellers)
  - Value: $22 million in cash
  - Effective: 2024-01-05
  source text: On January 5, 2024, OrthoPediatrics Corp. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Boston Brace International, Inc., a Massachusetts corporation (“Boston Brace”), the shareholders of Boston Brace (collectively, the “Sellers”), and the Sellers’ representative named therein (the “Sellers’ Representative”), pursuant to which the Company acquired all of the issued and outstanding shares of capital stock of Boston Brace from the Sellers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000110465924002071/0001104659-24-002071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.